28
Oct
2025

SYMERES B.V.

Exhibitor at CPHI Frankfurt 2025 stand 5.1A7, Contract Manufacturing and Services
About Us

Symeres is the leading mid-sized transatlantic Contract Research Organization for your drug discovery and development challenges.

With over 600 highly educated scientists in six locations in Europe and two in the USA, we offer best-in-class solutions for drug discovery and drug development, from small to medium-sized molecule hits. We are large enough to matter, and small enough to care.

Our services span across early stage hit finding all the way to the delivery of your early clinical drug substance API. Making Molecules Matter. Together.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • NL
  • 2021
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Contract Research Organisation (CRO)
Primary activities
Contract Research Organisation
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Frankfurt 2025
  • 28 Oct 2025 - 30 Oct 2025
  • Messe, Frankfurt
  • Visit us at stand 5.1A7, Contract Manufacturing and Services

Products Featured at CPHI Frankfurt 2025

  • Formulation Development and Clinical Manufacturing

    Product Formulation Development and Clinical Manufacturing

    We blend the art of formulation with advanced scientific tools to support drug product development from early stages through Phase 3, offering comprehensive manufacturing and regulatory services. It is often said that formulation is an art, not a science. Our art is supported by an extensive array of scie...
  • GMP Manufacturing

    Product GMP Manufacturing

    Close collaboration with our experienced process engineers aid our efforts achieve right first time scale-up of processes for GMP manufacture. The processes developed at our facilities are adapted to the plant environment in close collaboration with experienced process engineers. The limits of operating c...
  • Non-GMP scale-up for IND-enabling studies

    Product Non-GMP scale-up for IND-enabling studies

    Symeres has long-established expertise in non-GMP scale-up for IND-enabling studies, ensuring that our clients can confidently navigate the transition from laboratory-scale synthesis to clinical phases while minimizing costs and risks. The well-documented processes we provide significantly reduce the inh...
  • Route Scouting for challenging APIs

    Product Route Scouting for challenging APIs

    Symeres is well equipped to ideate around your challenging small molecule APIs
  • Solid-State Chemistry and Pre-Formulation Research

    Product Solid-State Chemistry and Pre-Formulation Research

    Our Solid-State experts can help you to selectively crystallize the optimal stable form and formulate your compound. A controlled crystallization is the preferred isolation method to obtain purified material of a specific polymorphic (salt) form and crystal habit. The solid form determines the stability, ...
  • Drug Discovery and Development of Lipids and small molecule APIs

    Product Drug Discovery and Development of Lipids and small molecule APIs

    Symeres can design, scale-up and manufacture novel lipids and small molecule APIs for wide variety of clients: small biotechs to large Pharma organizations
  • GMP Manufacturing of small molecule APIs

    Product GMP Manufacturing of small molecule APIs

    Symeres can upscale and manufacture novel APIs